Abstract
Papillary carcinomas are the most common thyroid malignancies. If the encapsulated follicular variant is left out as a distinct entity (precursor or borderline) as they show molecular and immunochemical features between follicular adenomas and papillary carcinomas, it is safe to say that vast majority of papillary carcinomas lack a capsule (exception: the rare macrofollicular variant) which is the trademark of follicular adenomas and carcinomas [1, 2]. Instead, they have infiltrative borders. The characteristic morphological of papillary carcinomas is papillae admixed with a variable portion of follicular structures. The neoplastic papillary structures are characterized by a branching structure composed of a delicate fibrovascular core lined by a one layer of atypical cells. The cliché “not all papillary carcinomas have a papillary growth pattern and not all papillary patterned thyroid lesions are papillary carcinoma” serves as a useful reminder for surgical pathologist but has led to the de-emphasis of the evaluation of the papillary structures in thyroid pathology. Actually the papillary structures in papillary carcinoma are more branching and contain more fibrovascular tissue than the simpler nonbranching papillae present in benign thyroid lesions such as nodular goiters and follicular adenomas [3]. The lining cells of the former are arranged in a nonpolar, haphazard pattern while the latter contains cells with basally located nuclei [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kakudo K, et al. Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer. Pathol Int. 2011;62(3):155–60.
Liu Z, et al. Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal. Cancer Sci. 2011;102(1):288–94.
Nikiforov YE, Ohori PN. Chapter 11. Papillary carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, editors. Diagnostic pathology and molecular genetics of the thyroid. Baltimore/Philadelphia: Lippincott Williams & Wilkins; 2009. p. 160–213.
Baloch ZW, LiVolsi VA. Etiology and significance of the optically clear nucleus. Endocr Pathol. 2002;13(4):289–99.
Rezk S, et al. beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas. Endocr Pathol. 2004;15(4):329–37.
Nikiforov YE, Ohori PN. Chapter 10. Follicular carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, editors. Diagnostic pathology and molecular genetics of the thyroid. Baltimore/Philadelphia: Lippincott Williams & Wilkins; 2009. p. 132–59.
Mete O, Rotstein L, Asa SL. Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol. 2009;17(2):386–91.
Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 2011;24(12):1545–52.
Lin X, et al. Follicular thyroid carcinoma invades venous rather than lymphatic vessels. Diagn Pathol. 2010;5:8.
Yasuda M, et al. Glucose transporter-1 expression in the thyroid gland: clinicopathological significance for papillary carcinoma. Oncol Rep. 2005;14(6):1499–504.
Aldred MA, et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol. 2004;22(17):3531–9.
Kim D, Kim H, Koo JS. Expression of caveolin-1, caveolin-2 and caveolin-3 in thyroid cancer and stroma. Pathobiology. 2012;79(1):1–10.
Sotgia F, et al. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res. 2011;13(4):213.
Sotgia F, et al. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol. 2011;7:423–67.
Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol. 2007;17(3):233–40.
Fagman H, Nilsson M. Morphogenesis of the thyroid gland. Mol Cell Endocrinol. 2010;323(1):35–54.
Mitchell JC, Parangi S. Angiogenesis in benign and malignant thyroid disease. Thyroid. 2005;15(6):494–510.
Gerard AC, et al. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab. 2003;88(10):4977–83.
Takamatsu J, et al. Peroxidase and coupling activities of thyroid peroxidase in benign and malignant thyroid tumor tissues. Thyroid. 1992;2(3):193–6.
Hama Y, et al. Three-dimensional structure of the micro-blood vessels in thyroid tumors analyzed by immunohistochemistry coupled with image analysis. Thyroid. 1999;9(9):927–32.
Katoh R, et al. Confocal laser scanning microscopic observation of angioarchitectures in human thyroid neoplasms. Hum Pathol. 1999;30(10):1226–31.
Biddinger PW. Chapter 114. Medullary carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, editors. Diagnostic pathology and molecular genetics of the thyroid. Baltimore/Philadelphia: Lippincott Williams & Wilkins; 2009. p. 249–302.
Okumura K, Shinohara M, Endo F. Capability of tissue stem cells to organize into salivary rudiments. Stem Cells Int. 2012;2012:502136.
Knox SM, et al. Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis. Science. 2010;329(5999):1645–7.
Guzzo M, et al. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74(2):134–48.
Leivo I. Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer. Acta Oncol. 2006;45(6):662–8.
Nagao T, et al. Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem. 2012;45(5):269–82.
Cheuk W, Chan JK. Advances in salivary gland pathology. Histopathology. 2007;51(1):1–20.
Ellis GL, Auclair PL. In: Silverberg SG, editor. Tumors of the salivary glands, AFIP atlas of tumor pathology. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2008. Chapter 5: malignant epithelial neoplasms.
Bhaijee F, et al. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma. Ann Diagn Pathol. 2011;15(1):69–77.
Ettl T, et al. Salivary gland carcinomas. Oral Maxillofac Surg. 2012;16(3):267–83.
Seethala RR. Histologic grading and prognostic biomarkers in salivary gland carcinomas. Adv Anat Pathol. 2011;18(1):29–45.
Ellis GL, Auclair PL. Chapter 5. Malignant epithelial neoplasms. In: Tumors of the salivary glands. Silver Spring: ARP Press; 2008. p. 173–438.
Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3(1):69–77.
Liu J, et al. Molecular biology of adenoid cystic carcinoma. Head Neck. 2011;34(11):1665–77.
Schwarz S, et al. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Int J Clin Exp Pathol. 2011;4(4):336–48.
Gordon J, Manley NR. Mechanisms of thymus organogenesis and morphogenesis. Development. 2011;138(18):3865–78.
Nowell CS, Farley AM, Blackburn CC. Thymus organogenesis and development of the thymic stroma. Methods Mol Biol. 2007;380:125–62.
Inoue M, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003;63(13):3708–15.
Alves NL, et al. Thymic epithelial cells: the multi-tasking framework of the T cell “cradle”. Trends Immunol. 2009;30(10):468–74.
Cimpean AM, et al. Platelet-derived growth factor and platelet-derived growth factor receptor-alpha expression in the normal human thymus and thymoma. Int J Exp Pathol. 2011;92(5):340–4.
Foster K, et al. Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol. 2008;180(5):3183–9.
Moran CA, Suster S. The World Health Organization (WHO) histologic classification of thymomas: a reanalysis. Curr Treat Options Oncol. 2008;9(4–6):288–99.
Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumors of the lung, pleura, thymus and heart, World Health Organization classification of tumours. Lyon: IARC Press; 2004.
Shimosato Y, Mukai K, Matsuno Y. Tumors of the mediastinum, AFIP atlas of tumor pathology series 4. Silver Spring: ARP Press; 2010. Chapter 2: thymoma.
Tomita M, et al. Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors. J Thorac Cardiovasc Surg. 2002;124(3):493–8.
Kojika M, et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol. 2009;22(10):1341–50.
Shimosato Y, Mukai K, Matsuno Y. Chapter 3. Thymic carcinoma. In: Tumors of the mediastinum. Silver Spring: ARP Press; 2010. p. 115–56.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sun, X. (2015). Thyroid Gland, Salivary Gland, and Thymus. In: Well-Differentiated Malignancies. Current Clinical Pathology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1692-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1692-4_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1691-7
Online ISBN: 978-1-4939-1692-4
eBook Packages: MedicineMedicine (R0)